Open navigation

Congratulations to Jeannie T. Lee, M.D., scientific co-founder of RaNA Therapeutics, on receiving this year's Lurie Prize in Biomedical Sciences from the FNIH.

RaNA Therapeutics Names Thomas McCauley as Chief Scientific Officer

Read More

How Cambridge’s RaNA is using RNA ‘dark matter’ to save babies

Read More

RaNA Awarded First Patent for Transcriptional Activation Platform

Read More

RaNA Therapeutics is pioneering the discovery of a novel approach that targets RNA within cells in the body to selectively activate protein expression.

RaNA’s oligonucleotide platform capabilities include blocking gene-repressive complexes and stabilizing mRNA half-life to upregulate, or increase, the level of important proteins in the body to treat or prevent disease.

LEARN ABOUT OUR PLATFORM

Meet the RaNA Team

We are innovative and fearless, taking bold steps and pushing boundaries to pioneer groundbreaking science.

MANAGEMENT TEAM BOARD OF DIRECTORS SCIENTIFIC ADVISORY BOARD BE FEARLESS